Explore the retrospective, cross-sectional study describing the treatment patterns of Oral Glucose-Lowering Drugs in Asian population, using the JADE (Joint Asia Diabetes Evaluation) Register.
Learn more about the retrospective study comparing the effectiveness of gliclazide MR 60 mg versus sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled T2D.
